These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35484936)

  • 21. Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke.
    Redfors B; Gray WA; Lee RJ; Ellenbogen KA; Bonafede M; Ben-Yehuda O
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1369-1376. PubMed ID: 29759666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
    Højen AA; Nielsen PB; Riahi S; Jensen M; Lip GYH; Larsen TB; Søgaard M
    Br J Clin Pharmacol; 2022 Aug; 88(8):3847-3855. PubMed ID: 35355307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.
    Jung H; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Thromb Haemost; 2019 Feb; 119(2):285-293. PubMed ID: 30602200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke.
    Kim JM; Park KY; Yu IW; Song TJ; Kim YJ; Kim BJ; Heo SH; Jung JM; Oh KM; Kim CK; Yu S; Park JH; Choi JC; Park MS; Kim JT; Choi KH; Hwang YH; Chung JW; Bang OY; Kim GM; Seo WK
    Eur J Neurol; 2020 May; 27(5):900-902. PubMed ID: 32064742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary stroke prophylaxis in atrial fibrillation patients with chronic kidney disease: a nationwide cohort study.
    Christensen MA; Fosbøl EL; Bonde AN; Olesen JB; Gislason GH; Torp-Pedersen C; Gundlund A
    Europace; 2020 May; 22(5):716-723. PubMed ID: 31872246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation Registry.
    Haeusler KG; Tütüncü S; Kunze C; Schurig J; Malsch C; Harder J; Wiedmann S; Dimitrijeski B; Ebinger M; Hagemann G; Hamilton F; Honermann M; Jungehulsing GJ; Kauert A; Koennecke HC; Leithner C; Mackert BM; Masuhr F; Nabavi D; Rocco A; Schmehl I; Schmitz B; Sparenberg P; Stingele R; von Brevern M; Völzke E; Dietzel J; Heuschmann PU; Endres M
    Europace; 2019 Nov; 21(11):1621-1632. PubMed ID: 31397475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study.
    Wang JR; Du X; Dong JZ; Chang SS; Jiang C; Sang CH; Long DY; Tang RB; Zhang HB; Guo JC; Wen YM; He L; Ma CS
    Clin Cardiol; 2022 Jan; 45(1):60-67. PubMed ID: 34952974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.
    Shin JI; Secora A; Alexander GC; Inker LA; Coresh J; Chang AR; Grams ME
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1144-1152. PubMed ID: 30002224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 33. Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation.
    Tiili P; Leventis I; Kinnunen J; Svedjebäck I; Lehto M; Karagkiozi E; Sagris D; Ntaios G; Putaala J
    Ann Med; 2021 Dec; 53(1):1613-1620. PubMed ID: 34498537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.
    Chu SY; Jiang J; Wang YL; Sheng QH; Zhou J; Ding YS
    Heart Lung; 2020; 49(1):66-72. PubMed ID: 31376922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study.
    Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Garrahy E; Bindoff I; Peterson GM
    J Am Heart Assoc; 2022 Apr; 11(7):e023098. PubMed ID: 35301852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study.
    Fauchier L; Clementy N; Bisson A; Stamboul K; Ivanes F; Angoulvant D; Babuty D; Lip GY
    Clin Res Cardiol; 2017 Mar; 106(3):202-210. PubMed ID: 27695988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Toorop MMA; Chen Q; Tichelaar VYIG; Cannegieter SC; Lijfering WM
    Eur Heart J; 2021 Oct; 42(40):4126-4137. PubMed ID: 34269375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in preadmission oral anticoagulant use and clinical outcome in atrial fibrillation patients admitted with acute stroke in Denmark.
    Larsen LK; Ovesen C; Frost L; Damgaard D; Christensen H; Johnsen SP
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):112-120. PubMed ID: 31855254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
    Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
    Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.